BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9846574)

  • 1. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.
    Desbarats J; Duke RC; Newell MK
    Nat Med; 1998 Dec; 4(12):1377-82. PubMed ID: 9846574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells.
    Kishimoto H; Sprent J
    J Immunol; 1999 Aug; 163(4):1817-26. PubMed ID: 10438914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
    Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
    J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
    Telford WG; Nam SY; Podack ER; Miller RA
    Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V; Winkel K; Süss G; Kelso A; Heath W; Kirberg J; von Boehmer H; Shortman K
    J Immunol; 1996 Nov; 157(9):3819-27. PubMed ID: 8892611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
    Singh RK; Varney ML; Buyukberber S; Ino K; Ageitos AG; Reed E; Tarantolo S; Talmadge JE
    Cancer Res; 1999 Jul; 59(13):3107-11. PubMed ID: 10397252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
    Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
    J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
    J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE; Bodey B
    In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression.
    Wang R; Brunner T; Zhang L; Shi Y
    Oncogene; 1998 Sep; 17(12):1503-8. PubMed ID: 9794227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
    Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
    J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
    Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
    J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress.
    Byrne SN; Halliday GM
    Cancer Immunol Immunother; 2003 Jun; 52(6):396-402. PubMed ID: 12739069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.